McCabe CH - Search Results

1

Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin.

Santopinto J, Gurfinkel EP, Torres V, Marcos E, Bozovich GE, Mautner B, McCabe CH, Antman EM. Santopinto J, et al. Among authors: mccabe ch. Am Heart J. 2001 Apr;141(4):566-72. doi: 10.1067/mhj.2001.113994. Am Heart J. 2001. PMID: 11275921 Clinical Trial.

2

Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction.

Antman EM, McCabe CH, Braunwald E. Antman EM, et al. Among authors: mccabe ch. Am Heart J. 2002 Feb;143(2):229-34. doi: 10.1067/mhj.2002.120405. Am Heart J. 2002. PMID: 11835024 Clinical Trial.

3

Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time.

Bozovich GE, Gurfinkel EP, Antman EM, McCabe CH, Mautner B. Bozovich GE, et al. Among authors: mccabe ch. Am Heart J. 2000 Oct;140(4):637-42. doi: 10.1067/mhj.2000.109921. Am Heart J. 2000. PMID: 11011339 Clinical Trial.

4

Identification of patients at high risk for death and cardiac ischemic events after hospital discharge.

Sabatine MS, McCabe CH, Morrow DA, Giugliano RP, de Lemos JA, Cohen M, Antman EM, Braunwald E. Sabatine MS, et al. Among authors: mccabe ch. Am Heart J. 2002 Jun;143(6):966-70. doi: 10.1067/mhj.2002.122870. Am Heart J. 2002. PMID: 12075250 Clinical Trial.

5

Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).

Antman EM, Morrow DA, McCabe CH, Jiang F, White HD, Fox KA, Sharma D, Chew P, Braunwald E; ExTRACT-TIMI 25 Investigators. Antman EM, et al. Among authors: mccabe ch. Am Heart J. 2005 Feb;149(2):217-26. doi: 10.1016/j.ahj.2004.08.038. Am Heart J. 2005. PMID: 15846258 No abstract available.

6

Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction.

Sabatine MS, Morrow DA, McCabe CH, Antman EM, Gibson CM, Cannon CP. Sabatine MS, et al. Among authors: mccabe ch. Am Heart J. 2006 Jan;151(1):25-31. doi: 10.1016/j.ahj.2005.02.030. Am Heart J. 2006. PMID: 16368287 Clinical Trial.

7

Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).

Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald E; TRITON-TIMI 38 Investigators. Wiviott SD, et al. Among authors: mccabe ch. Am Heart J. 2006 Oct;152(4):627-35. doi: 10.1016/j.ahj.2006.04.012. Am Heart J. 2006. PMID: 16996826 Clinical Trial.

8

Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction.

Giraldez RR, Sabatine MS, Morrow DA, Mohanavelu S, McCabe CH, Antman EM, Braunwald E. Giraldez RR, et al. Among authors: mccabe ch. Am Heart J. 2009 Mar;157(3):517-24. doi: 10.1016/j.ahj.2008.10.021. Am Heart J. 2009. PMID: 19249423

9

One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial.

Morrow DA, Antman EM, Fox KA, White HD, Giugliano R, Murphy SA, McCabe CH, Braunwald E; ExTRACT-TIMI 25 Investigators. Morrow DA, et al. Among authors: mccabe ch. Eur Heart J. 2010 Sep;31(17):2097-102. doi: 10.1093/eurheartj/ehq098. Epub 2010 Apr 17. Eur Heart J. 2010. PMID: 20400762 Clinical Trial.

10

Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE.

Antman EM, Cohen M, McCabe C, Goodman SG, Murphy SA, Braunwald E; TIMI 11B and ESSENCE Investigators. Antman EM, et al. Eur Heart J. 2002 Feb;23(4):308-14. doi: 10.1053/euhj.2001.2779. Eur Heart J. 2002. PMID: 11812067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters